(Q35563622)

8 August 2017

1 reference

title

Management of acquired haemophilia A--more questions than answers (English)

1 reference

8 August 2017

Management of acquired haemophilia A - more questions than answers (English)

1 reference

https://api.crossref.org/works/10.1097/00001721-200306001-00006

23 March 2024

0 references

0 references

Peter W. Collins

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567531

23 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14567531

23 March 2024

publication date

1 June 2003

1 reference

full work available at URL

8 August 2017

http://journals.lww.com/00001721-200306001-00006

1 reference

https://api.crossref.org/works/10.1097/00001721-200306001-00006

Blood Coagulation and Fibrinolysis

23 March 2024

published in

1 reference

8 August 2017

volume

14 Suppl 1

1 reference

8 August 2017

page(s)

S23-7

1 reference

Postpartum acquired factor VIII inhibitors: results of a survey

8 August 2017

cites work

6

1 reference

https://api.crossref.org/works/10.1097/00001721-200306001-00006

Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals

23 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/00001721-200306001-00006

Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor

23 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00001721-200306001-00006

23 March 2024

10

85

64

Nemes

2000

1 reference

https://api.crossref.org/works/10.1097/00001721-200306001-00006

Intravenous immunoglobulin in the treatment of spontaneously acquired factor VIII:C inhibitors

23 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00001721-200306001-00006

Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review.

23 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00001721-200306001-00006

Rituximab in the treatment of acquired factor VIII inhibitors

23 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00001721-200306001-00006

Acquired haemophilia: experiences with a standardized approach

23 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00001721-200306001-00006

DDAVP in acquired hemophilia A: case report and review of the literature

23 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00001721-200306001-00006

Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb).

23 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00001721-200306001-00006

Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophilia.

23 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00001721-200306001-00006

23 March 2024

Identifiers

1 reference

8 August 2017

1 reference